Piper Jaffray Starts Theravance Biopharma (TBPH) at Overweight

November 3, 2016 7:18 AM EDT
Get Alerts TBPH Hot Sheet
Price: $31.19 -2.47%

Rating Summary:
    5 Buy, 0 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 23 | Down: 34 | New: 34
Trade TBPH Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Piper Jaffray initiated coverage on Theravance Biopharma (NASDAQ: TBPH) with an Overweight rating and a price target of $42.

For an analyst ratings summary and ratings history on Theravance Biopharma click here. For more ratings news on Theravance Biopharma click here.

Shares of Theravance Biopharma closed at $25.10 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Piper Jaffray

Add Your Comment